These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11849768)

  • 1. Mutation analysis of the calpastatin gene (CAST) in patients with Alzheimer's disease.
    Nakayama J; Yoshizawa T; Yamamoto N; Arinami T
    Neurosci Lett; 2002 Mar; 320(1-2):77-80. PubMed ID: 11849768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
    Rao MV; Mohan PS; Peterhoff CM; Yang DS; Schmidt SD; Stavrides PH; Campbell J; Chen Y; Jiang Y; Paskevich PA; Cataldo AM; Haroutunian V; Nixon RA
    J Neurosci; 2008 Nov; 28(47):12241-54. PubMed ID: 19020018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytic calpain-calpastatin system in Alzheimer's disease.
    Soldati L; Alberoni M; Bianchi G; Canal N; Franceschi M
    Aging (Milano); 1996 Apr; 8(2):106-8. PubMed ID: 8737608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology.
    Higuchi M; Iwata N; Matsuba Y; Takano J; Suemoto T; Maeda J; Ji B; Ono M; Staufenbiel M; Suhara T; Saido TC
    FASEB J; 2012 Mar; 26(3):1204-17. PubMed ID: 22173972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
    Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
    FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease.
    Oda M; Morino H; Maruyama H; Terasawa H; Izumi Y; Torii T; Sasaki K; Nakamura S; Kawakami H
    Neurosci Lett; 2002 Mar; 320(1-2):105-7. PubMed ID: 11849775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease.
    Brune S; Kölsch H; Ptok U; Majores M; Schulz A; Schlosser R; Rao ML; Maier W; Heun R
    J Neural Transm (Vienna); 2003 Sep; 110(9):1041-50. PubMed ID: 12938026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new single nucleotide polymorphism in the calpastatin (CAST) gene associated with beef tenderness.
    Calvo JH; Iguácel LP; Kirinus JK; Serrano M; Ripoll G; Casasús I; Joy M; Pérez-Velasco L; Sarto P; Albertí P; Blanco M
    Meat Sci; 2014 Feb; 96(2 Pt A):775-82. PubMed ID: 24200570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.
    Athan ES; Williamson J; Ciappa A; Santana V; Romas SN; Lee JH; Rondon H; Lantigua RA; Medrano M; Torres M; Arawaka S; Rogaeva E; Song YQ; Sato C; Kawarai T; Fafel KC; Boss MA; Seltzer WK; Stern Y; St George-Hyslop P; Tycko B; Mayeux R
    JAMA; 2001 Nov; 286(18):2257-63. PubMed ID: 11710891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel polymorphisms of the amyloid precursor protein (APP) gene in Chinese/Taiwanese patients with Alzheimer's disease.
    Thajeb P; Wang P; Chien CL; Harrigan R
    J Clin Neurosci; 2009 Feb; 16(2):259-63. PubMed ID: 19097908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistasis between calpain 1 and its inhibitor calpastatin within breeds of cattle.
    Barendse W; Harrison BE; Hawken RJ; Ferguson DM; Thompson JM; Thomas MB; Bunch RJ
    Genetics; 2007 Aug; 176(4):2601-10. PubMed ID: 17603104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T; Barnoy S; Kosower NS
    Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.
    Nixon RA; Saito KI; Grynspan F; Griffin WR; Katayama S; Honda T; Mohan PS; Shea TB; Beermann M
    Ann N Y Acad Sci; 1994 Dec; 747():77-91. PubMed ID: 7847693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.